Reperfusion is a stronger predictor of good clinical outcome than recanalization in ischemic stroke

Radiology

Volumn 269, Issue 1, 2013, Pages 240-248

  Eilaghi, Armin ^a,b   Brooks, John ^b   D'Esterre, Christopher ^a   Zhang, Liying ^c   Swartz, Richard H ^c   Lee, Ting Yim ^a   Aviv, Richard I ^b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BLOOD VOLUME; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN SIZE; COHORT ANALYSIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIABETES MELLITUS; FEMALE; FOLLOW UP; GOOD CLINICAL PRACTICE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; IMAGE ANALYSIS; IMAGE PROCESSING; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RANK SUM TEST; RANKIN SCALE; RATING SCALE; RECANALIZATION; RECEIVER OPERATING CHARACTERISTIC; REPERFUSION; SMOKING; TIME TO MAXIMUM PLASMA CONCENTRATION; WHITE MATTER;

AGED; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CEREBRAL REVASCULARIZATION; FEMALE; HUMANS; MALE; ONTARIO; PERFUSION IMAGING; PREVALENCE; PROGNOSIS; REPERFUSION; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STROKE; TREATMENT OUTCOME;

EID: 84884682314     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13122327     Document Type: Article

References (43)

1. Nogueira RG, Liebeskind DS, Sung G, et al. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke 2009;40(12):3777-3783.
2. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a metaanalysis. Stroke 2007;38(3):967-973. (Pubitemid 46568460)
3. Zaidat OO, Suarez JI, Sunshine JL, et al. Thrombolytic therapy of acute ischemic stroke: correlation of angiographic recanalization with clinical outcome. AJNR Am J Neuroradiol 2005;26(4):880-884. (Pubitemid 43079785)
4. del Zoppo GJ, Koziol JA. Recanalization and stroke outcome. Circulation 2007;115(20):2602-2605. (Pubitemid 46791357)
5. Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992;42(5):976-982.
6. Khatri P, Neff J, Broderick JP, et al. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005;36(11):2400-2403. (Pubitemid 41566966)
7. Soares BP, Chien JD, Wintermark M. MR and CT monitoring of recanalization, reperfusion, and penumbra salvage: everything that recanalizes does not necessarily reperfuse! Stroke 2009;40(3 Suppl):S24-S27.
8. Tomsick T. TIMI, TIBI, TICI: I came, I saw, I got confused. AJNR Am J Neuroradiol 2007;28(2):382-384.
9. del Zoppo GJ. Virchow's triad: the vascular basis of cerebral injury. Rev Neurol Dis 2008;5(Suppl 1):S12-S21.
10. Ames A 3rd, Wright RL, Kowada M, Thurston JM, Majno G. Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol 1968;52(2):437-453.
11. Qureshi AI, Hussein HM, Abdelmoula M, Georgiadis AL, Janjua N. Subacute recanalization and reocclusion in patients with acute ischemic stroke following endovascular treatment. Neurocrit Care 2009;10(2):195-203.
12. Qureshi AI, Siddiqui AM, Kim SH, et al. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2004;25(2):322-328. (Pubitemid 38235318)
13. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002;59(6):862-867.
14. Soares BP, Tong E, Hom J, et al. Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization: a proof of concept using CT in acute ischemic stroke patients. Stroke 2010;41(1):e34-e40.
15. Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med 1999;340(23):1781-1787.
16. Bruno A, Biller J, Adams HP Jr, et al. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999;52(2):280-284.
17. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997;28(11):2119-2125.
18. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 2000;55(11):1649-1655.
19. Adams HP Jr, Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34(4):1056-1083. (Pubitemid 36402991)
20. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333(24):1581-1587.
21. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274(13):1017-1025.
22. Tan IY, Demchuk AM, Hopyan J, et al. CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. AJNR Am J Neuroradiol 2009;30(3):525-531.
23. Puetz V, Dzialowski I, Hill MD, et al. Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Int J Stroke 2008;3(4):230-236.
24. Sillanpaa N, Saarinen JT, Rusanen H, et al. The clot burden score, the Boston Acute Stroke Imaging Scale, the cerebral blood volume ASPECTS, and two novel imaging parameters in the prediction of clinical outcome of ischemic stroke patients receiving intravenous thrombolytic therapy. Neuroradiology 2012;54(7):663-672.
25. von Kummer R, Weber J. Brain and vascular imaging in acute ischemic stroke: the potential of computed tomography. Neurology 1997;49(5 Suppl 4):S52-S55. (Pubitemid 27495608)
26. Demchuk AM, Coutts SB. Alberta Stroke Program Early CT Score in acute stroke triage. Neuroimaging Clin N Am 2005;15(2):409-419, xii. (Pubitemid 41405773)
27. Kim JT, Park MS, Choi KH, et al. The CBV-ASPECT Score as a predictor of fatal stroke in a hyperacute state. Eur Neurol 2010;63(6):357-363.
28. Murphy BD, Fox AJ, Lee DH, et al. White matter thresholds for ischemic penumbra and infarct core in patients with acute stroke: CT perfusion study. Radiology 2008;247(3):818-825.
29. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000;355(9216):1670-1674. (Pubitemid 30248478)
30. Kim JJ, Fischbein NJ, Lu Y, Pham D, Dillon WP. Regional angiographic grading system for collateral flow: correlation with cerebral infarction in patients with middle cerebral artery occlusion. Stroke 2004;35(6):1340-1344. (Pubitemid 38697454)
31. Kamalian S, Kamalian S, Maas MB, et al. CT cerebral blood flow maps optimally correlate with admission diffusion-weighted imaging in acute stroke but thresholds vary by postprocessing platform. Stroke 2011;42(7):1923-1928.
32. Campbell BC, Christensen S, Levi CR, et al. Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke 2011;42(12):3435-3440.
33. Tamura A, Murakami K, Kadota J; OITA-GF Study Investigators. Prevalence and independent factors for gastroduodenal ulcers/erosions in asymptomatic patients taking low-dose aspirin and gastroprotective agents: the OITA-GF study. QJM 2011;104(2):133-139.
34. Meurer WJ, Scott PA, Caveney AF, et al. Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator. Int J Stroke 2010;5(3):163-166.
35. Olivot J-M, Mlynash M, Thijs VN, et al. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke 2009;40(2):469-475.
36. Kamalian S, Kamalian S, Konstas AA, et al. CT perfusion mean transit time maps optimally distinguish benign oligemia from true "at-risk" ischemic penumbra, but thresholds vary by postprocessing technique. AJNR Am J Neuroradiol 2012;33(3):545-549.
37. Leiva-Salinas C, Provenzale JM, Kudo K, Sasaki M, Wintermark M. The alphabet soup of perfusion CT and MR imaging: terminology revisited and clarified in five questions. Neuroradiology 2012;54(9):907-918.
38. Weimar C, König IR, Kraywinkel K, Ziegler A, Diener HC; German Stroke Study Collaboration. Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke 2004;35(1):158-162. (Pubitemid 38057612)
39. Murphy BD, Fox AJ, Lee DH, et al. Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements. Stroke 2006;37(7):1771-1777. (Pubitemid 44297728)
40. van Everdingen KJ, van der Grond J, Kappelle LJ, Ramos LM, Mali WP. Diffusionweighted magnetic resonance imaging in acute stroke. Stroke 1998;29(9):1783-1790 (Pubitemid 28399964)
41. Gaudinski MR, Henning EC, Miracle A, Luby M, Warach S, Latour LL. Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant. Stroke 2008;39(10):2765-2768.
42. Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-2 (DEFUSE-2). http://clinicaltrials.gov/show/NCT01349946. Accessed May 11, 2012.
43. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368(10):893- 903.